Crystal Pharmatech is a specialized Contract Research Organization/Contract Development and Manufacturing Organization (CRO/CDMO) that excels in crystal form and formulation services for the pharmaceutical industry. Established in 2010, the company focuses on solid-state research, crystallization, pre-formulation, formulation development, and manufacturing. With a global presence, Crystal Pharmatech operates three strategically located R&D centres in Suzhou (China), New Jersey (USA), and Toronto (Canada). The company is powered by a skilled team of approximately 250 professionals who are dedicated to ensuring the highest quality of service and innovation.

Services include:
– Solid Dosage
– Clinical Dose
– Packaging
– Clinical Packaging
– Analytical Services
– Regulatory Services

Crystal Pharmatech is committed to delivering robust API forms and scalable manufacturing processes, culminating in a First-Time-Right formulation for Phase I. For more information, please visit crystalpharmatech.com.